切换至 "中华医学电子期刊资源库"

中华临床医师杂志(电子版) ›› 2019, Vol. 13 ›› Issue (04) : 300 -303. doi: 10.3877/cma.j.issn.1674-0785.2019.04.012

所属专题: 文献

综述

吲哚菁绿清除试验在肝癌治疗中的应用进展
邹松龙1, 胥莹1,(), 张雪1, 吴杰芳1, 孟淑慧1   
  1. 1. 650101 昆明医科大学附属第二医院消化内科
  • 收稿日期:2018-10-12 出版日期:2019-02-15
  • 通信作者: 胥莹

Application of indocyanine green scavenging test in treatment of liver cancer

Songlong Zou1, Ying Xu1,(), Xue Zhang1, Jiefang Wu1, Shuhui Meng1   

  1. 1. Department of Gastroenterology, the Second Affiliated Hospital of Kunming Medical University, Kunming 650101, China
  • Received:2018-10-12 Published:2019-02-15
  • Corresponding author: Ying Xu
  • About author:
    Corresponding author: Xu Ying, Email:
引用本文:

邹松龙, 胥莹, 张雪, 吴杰芳, 孟淑慧. 吲哚菁绿清除试验在肝癌治疗中的应用进展[J/OL]. 中华临床医师杂志(电子版), 2019, 13(04): 300-303.

Songlong Zou, Ying Xu, Xue Zhang, Jiefang Wu, Shuhui Meng. Application of indocyanine green scavenging test in treatment of liver cancer[J/OL]. Chinese Journal of Clinicians(Electronic Edition), 2019, 13(04): 300-303.

肝癌是一种严重威胁人类健康的疾病,肝癌治疗前需要进行肝储备功能评估,但由于肝结构与功能的复杂性,目前尚无可全面评估肝功能的方法,吲哚菁绿清除试验作为一种能够动态地、迅速地评估肝储备功能的方法被广泛应用于肝癌治疗中肝储备功能评估。本文分析归纳了吲哚菁绿清除试验在肝癌治疗肝储备功能评估中的应用,得出吲哚青绿清除试验在肝癌治疗尤其在肝切除术时能够准确评估肝储备功能,预测术后肝功能不全。

Liver cancer is a serious threat to human health. Liver reserve function assessment is needed before liver cancer treatment. However, due to the complexity of liver structure and function, there has been no comprehensive method for evaluating liver function. The indocyanine green scavenging test is a method for assessing liver reserve function dynamically and rapidly, and it is widely used in the evaluation of liver reserve function in liver cancer treatment. This paper discusses the application of the indocyanine green scavenging test in the evaluation of hepatic reserve function in liver cancer treatment. It is concluded that the indocyanine green scavenging test can accurately assess liver reserve function and predict postoperative liver dysfunction in liver cancer treatment, especially liver resection.

1
罗敏玲. 肝病患者吲哚菁绿清除试验的护理对策 [J]. 当代护士(上旬刊), 2017(9): 142-143.
2
Vos JJ, Wietasch JK, Absalom AR, et al. Green light for liver function monitoring using indocyanine green? An overview of current clinical applications [J]. Anaesthesia, 2014, 69(12): 1364-1376.
3
Lutz Schneider, Martin Spiegel, Sebastian Latanowicz, et al. Noninvasive indocyanine green plasma disappearance rate predicts early complications, graft failure or death after liver transplantation [J]. Hepatobiliary & Pancreatic Diseases International, 2011, 10(4): 362-368.
4
Schneider L, Spiegel M, Latanowicz S, et al. Noninvasive indocyanine green plasma disappearance rate predicts early complications, graft failure or death after liver transplantation [J]. Hepatobiliary Pancreat Dis Int, 2011, 10(4): 362-368.
5
庄波,金如燕,厉学民, 等. 测定肝功能时吲哚菁绿清除试验的影响因素分析[J]. 肝胆胰外科杂志, 2013, 25(4): 336-338.
6
Halle BM, Poulsen TD, Pedersen HP. Indocyanine green plasma disappearance rate as dynamic liver function test in critically ill patients [J]. Acta Anaesthesiol Scand, 2014, 58: 1214-1219.
7
Ge PL, Du SD, Mao YL. Advances in preoperative assessment of liver function [J]. Hepatobiliary Pancreat Dis Int, 2014, 13(4): 361-370.
8
Mizuguchi T, Kawamoto M, Meguro M, et al. Preoperative liver function assessments to estimate the prognosis and safety of liver resections [J]. Surg Today, 2014, 44(1): 1-10.
9
Faybik P, Krenn CG, Baker A, et al. Comparison of invasive and noninvasive measurement of plasma disappearance rate of indocyanine green in patients undergoing liver transplantation: a prospective investigator-blinded study [J]. Liver Transpl, 2004, 10(8): 1060-1064.
10
Sultana A, Brooke-Smith M, Ullah S, et al. Prospective evaluation of the International Study Group for Liver Surgery definition of post hepatectomy liver failure after liver resection: an international multicentre study [J]. HPB (Oxford), 2018, 20(5): 462-469.
11
Kokudo N, Makuuchi M. Evidence-based clinical practice guidelines for hepatocellular carcinoma in Japan: the J-HCC guidelines [J]. J Gastroenterol, 2009, 44 Suppl 19: 119-121.
12
Mobley CM, Zarrinpar A. Portable device for the analysis of liver function: a boon to liver surgery and critical care [J]. Expert Rev Med Devices, 2016, 13(1): 1-4.
13
Lao XM, Zhang YQ, Guan YX, et al. Evaluation of Liver Reserve Function by ICG_(R15) Dtection Before Hepatectomy for Hepatocellular Carcinoma [J]. Chinese Journal of Cancer, 2004, 23(10): 1213-1217.
14
Wu ZQ, Wang WD, Lin J, et al. Application of indocyanine green clearance test for assessing preoperative liver reserve function in hepatocellular carcinoma patients [J]. J Clin Hepatol, 2015, 15(4): 389-393.
15
中华人民共和国卫生部. 原发性肝癌诊疗规范(2011年版) [J]. 临床肝胆病杂志, 2011, 27(11): 1141-1159.
16
Kim HJ, Kim CY, Park EK, et al. Volumetric analysis and indocyanine green retention rate at 15 min as predictors of post-hepatectomy liver failure [J]. HPB, 2015, 17(2): 159-167.
17
Ibis C, Albayrak D, Sahiner T, et al. Value of Preoperative Indocyanine Green Clearance Test for Predicting Post-Hepatectomy Liver Failure in Noncirrhotic Patients [J]. Med Sci Monit, 2017, 23: 4973-4980.
18
Thomas MN, Weninger E, Angele M, et al. Intraoperative simulation of remnant liver function during anatomic liver resection with indocyanine green clearance (LiMON) measurements [J]. HPB, 2015, 17(6): 471-476.
19
Yadav SK, Saraf N, Saigal S, et al. High MELD score does not adversely affect outcome of living donor liver transplantation: Experience in 1000 recipients [J]. Clin Transplant, 2017, 31(8).
20
Zarrinpar A, Lee C, Noguchi E, et al. A rapid, reproducible, noninvasive predictor of liver graft survival [J]. J Surg Res, 2015, 197(1): 183-190.
21
Hernández Conde M, Llop Herrera E, de la Revilla Negro J, et al. Prevalence and outcome of portal thrombosis in a cohort of cirrhotic patients undergoing liver transplantation [J]. Rev Esp Enferm Dig, 2016, 108(11): 716-720.
22
Kawaguchi Y, Akamatsu N, Ishizawa T, et al. Evaluation of hepatic perfusion in the liver graft using fluorescence imaging with indocyanine green [J]. Int J Surg Case Rep, 2015, 14: 149-51
23
Jain S, Gamanagatti SR, Kedia S, et al. Role of Indocyanine Green in Predicting Post-Transarterial Chemoembolization Liver Failure in Hepatocellular Carcinoma [J]. J Clin Exp Hepatol, 2018, 8(1): 28-34.
24
Mizumoto M, Oshiro Y, Okumura T, et al. Association between pretreatment retention rate of indocyanine green 15 min after administration and life prognosis in patients with HCC treated by proton beam therapy [J]. Radiother Oncol, 2014, 113(1): 54-59.
[1] 周世振, 朱兴亚, 袁庆港, 刘理想, 王凯, 缪骥, 丁超, 汪灏, 管文贤. 吲哚菁绿荧光成像技术在腹腔镜直肠癌侧方淋巴结清扫中的应用效果分析[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 44-47.
[2] 唐梅, 周丽, 牛岑月, 周小童, 王倩. ICG荧光导航的腹腔镜肝切除术临床意义[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 655-658.
[3] 王兴, 文阳辉, 姚戈冰, 郭平学, 杨自华. ICG荧光腹腔镜下胆囊切除术的临床应用[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 663-666.
[4] 宋佳, 汪波, 孙凯律, 商江峰, 吴旦平, 肇毅. 吲哚菁绿荧光显影联合亚甲蓝染色在乳腺癌前哨淋巴结活检中的应用[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(05): 498-501.
[5] 胡森焱, 徐冬, 方健, 谢冬冬, 王财庆. ICG荧光显影Laennec膜入路腹腔镜解剖性肝切除的临床研究[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(05): 513-516.
[6] 高金红, 陈玉梅, 郭韵. 基于King互动达标理论的心理疏导在腹腔镜肝癌切除术患者的应用效果分析[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(05): 517-520.
[7] 林巧, 周丽. RFA联合LAH术治疗原发性肝癌并门静脉癌栓的临床效果分析[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(05): 521-524.
[8] 曾繁利, 齐秩凯, 杨贺庆. 两种经Glisson蒂鞘解剖路径肝切除术治疗原发性肝癌的肿瘤学疗效及风险比对[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(05): 525-527.
[9] 王飞, 陈政, 余德才, 曹亚娟. 原发性肝癌合并门静脉高压症的微创手术治疗[J/OL]. 中华腔镜外科杂志(电子版), 2024, 17(05): 306-310.
[10] 张敏, 朱建华, 缪雅芳, 郭锦荣. 菝葜皂苷元对肝癌HepG2细胞抑制作用的机制研究[J/OL]. 中华细胞与干细胞杂志(电子版), 2024, 14(06): 328-335.
[11] 袁雨涵, 杨盛力. 体液和组织蛋白质组学分析在肝癌早期分子诊断中的研究进展[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 883-888.
[12] 吴警, 吐尔洪江·吐逊, 温浩. 肝切除术前肝功能评估新进展[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 889-893.
[13] 广东省护士协会介入护士分会, 广东省医师协会介入医师分会. 原发性肝癌低血糖患者护理规范管理专家共识[J/OL]. 中华临床医师杂志(电子版), 2024, 18(08): 709-714.
[14] 韦巧玲, 黄妍, 赵昌, 宋庆峰, 陈祖毅, 黄莹, 蒙嫦, 黄靖. 肝癌微波消融术后中重度疼痛风险预测列线图模型构建及验证[J/OL]. 中华临床医师杂志(电子版), 2024, 18(08): 715-721.
[15] 蔡晓雯, 李慧景, 丘婕, 杨翼帆, 吴素贤, 林玉彤, 何秋娜. 肝癌患者肝动脉化疗栓塞术后疼痛风险预测模型的构建及验证[J/OL]. 中华临床医师杂志(电子版), 2024, 18(08): 722-728.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?